Health Care

John Hancock to offer rewards to holders who achieve health goals

CEO of John Hancock
CEO of John Hancock Financial Services Marianne Harrison. Photo: Dina Rudick/The Boston Globe via Getty Images.

John Hancock, one of the largest North American life insurers, will only sell policies that include the tracking of fitness and health data through wearable devices and smartphones, the company said on Wednesday.

The details: The company's underwriting process will still exist, but all policies will include the wellness program, called Vitality. Policyholders will be rewarded with discounts on their premiums and gift cards to popular stores when they achieve goals in a points system.

U.K. says new cancer therapy is too expensive

The Novartis headquarters building in Switzerland.
Novartis makes Kymriah, a new cancer treatment. Photo: Fabrice Coffrini/AFP via Getty Images

NICE, the governmental group in the United Kingdom that evaluates the value of drugs and treatments, has recommended against the use of a new $371,000 cancer therapy made by Novartis. It said the drug is "too expensive" for the population it would treat and that Novartis' "confidential discount" was not steep enough.

Why it matters: NICE's recommendation comes about a month after it said a similar treatment, known as CAR-T and made by Gilead Sciences, also is too pricey. An independent U.S. body said this year the two therapies were mostly cost-effective, but their high price tags still worry clinicians and policymakers.